|
LATISSE® (bimatoprost
ophthalmic solution) 0.03% is the first and only prescription
treatment approved by the FDA for inadequate or not
having enough eyelashes, growing them longer, fuller
and darker.
LATISSE® makes lash growth possible because of its
active ingredient: bimatoprost. Although the precise
mechanism of action is not known, research suggests
that the growth of eyelashes occurs by increasing the
percent of hairs in, and the duration of, the anagen
(or growth) phase. Lashes can grow longer, thicker and
darker because bimatoprost can also prolong this growth
phase.
LATISSE® is FDA approved and effective. It's a once-a-day
treatment you apply topically to the base of your upper
eyelashes. Patients in a clinical trial saw results
in as few as 8 weeks with full results after 12 to 16
weeks.
While LATISSE® is a treatment for inadequate or
not enough eyelashes, it was developed through years
of research by Allergan, a pharmaceutical leader with
over 60 years of expertise in prescription eye care
products.

Q & A with Gary Kawesch, MD:
|